WDHD1 and nasopharyngeal carcinoma: Furthermore, bioinformatic analyses have indicated that WDHD1 could serve as a discriminatory biomarker for distinguishing the NPC cohort from the non-cancer control group, holding promise as a novel screening molecule for NPC.